retatrutide weight loss phase 2 trial Results: 28.3% Data Great news again!!! A phase

The providers are very knowledgable, familiar with my medical history, answer all my questions and truly seem to care about my safety and success with the program

Gastrointestinal disturbances occur less frequently with phentermine compared to GLP-1 receptor agonists, making it a consideration for GLP-1 agonist non-responders who experience intolerable digestive issues

This leads to steadier energy levels and better metabolic stability (NIH)

This article provides a factual overview of all three compounds, their mechanisms, and how they compare based on published clinical trial data

For decades, investigators have sought structures resembling synapses in the intestinal mucosa, but without success 47,48,49,50,51,52,53,54

When starting a GLP-1 medication like Ozempic, Wegovy, Mounjaro, or Zepbound, you begin at a very low dose